| Not Yet Recruiting | Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 2-6 Years Epidemic Meningitis, Meningococcal Vaccines | Phase 3 | 2026-03-22 |
| Not Yet Recruiting | Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 6-11 Months Epidemic Meningitis, Meningococcal Vaccines | Phase 3 | 2026-03-22 |
| Not Yet Recruiting | Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months Epidemic Meningitis, Meningococcal Vaccines | Phase 3 | 2026-03-22 |
| Not Yet Recruiting | Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 3-5 Months Epidemic Meningitis, Meningococcal Vaccines | Phase 3 | 2026-03-22 |
| Not Yet Recruiting | Study to Evaluate the Safety of a Lyophilized RSV mRNA Vaccine RSV, mRNA Vaccine | Phase 1 | 2026-03-09 |
| Not Yet Recruiting | Phase IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine Rabies (Healthy Volunteers) | Phase 3 | 2026-03-04 |
| Not Yet Recruiting | Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Re Rabies (Healthy Volunteers) | Phase 3 | 2026-03-01 |
| Not Yet Recruiting | Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen Rabies | Phase 3 | 2026-03-01 |
| Recruiting | Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine Herpes Zoster, mRNA Vaccine | Phase 1 / Phase 2 | 2026-01-06 |
| Recruiting | Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vacci Poliomyelitis | Phase 4 | 2025-11-27 |
| Recruiting | Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Pregnant Women Influenza | Phase 3 | 2025-10-13 |
| Recruiting | Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations Poliomyelitis | Phase 4 | 2025-09-26 |
| Not Yet Recruiting | Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell) Rabies | Phase 2 | 2025-07-28 |
| Completed | Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell). Hand, Foot, and Mouth Disease (HFMD), Herpangina | Phase 1 / Phase 2 | 2025-01-15 |
| Recruiting | Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell) Hand, Foot, and Mouth Disease（HFMD) | Phase 3 | 2024-12-13 |
| Completed | Booster Dose of sIPV Co-administered With MMR and HepA-I. Poliomyelitis | Phase 4 | 2024-08-08 |
| Completed | Sequential Vaccination of Poliomyelitis Vaccine (Vero Cells), Inactivated, Sabin Strains From Different Manufa Poliomyelitis | Phase 4 | 2024-05-20 |
| Unknown | Active Case Finding of Clinical Hand Foot Mouth Disease in Children Aged 6 Months Old to 18 Years Old in Indon Hand, Foot and Mouth Disease | — | 2024-02-01 |
| Unknown | The Immunogenicity and Safety of the Booster Doses of a Live-attenuated Mumps Vaccine in Junior High School St Mumps, Influenza | Phase 4 | 2023-11-04 |
| Active Not Recruiting | Immunogenicity and Safety of Hepatitis A Among People Aged 18-50 Years Old Hepatitis A | Phase 4 | 2023-10-24 |
| Active Not Recruiting | Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial Hand, Foot and Mouth Disease, Herpangina | Phase 1 / Phase 2 | 2023-09-20 |
| Completed | A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months Seasonal Influenza | Phase 3 | 2023-09-16 |
| Unknown | Immunogenicity of After Primary Immunization and Booster Immunization of sIPV Polio | — | 2023-08-16 |
| Completed | A Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial of sIPV Vaccine Poliomyelitis, Polio | Phase 3 | 2023-05-22 |
| Completed | Lot-to-lot Consistency of 23-valent Pneumococcal Polysaccharide Vaccine Pneumococcal Infections | Phase 4 | 2023-02-27 |
| Completed | A Serosurvey Study of Hand, Foot, and Mouth Disease in Indonesia Hand, Foot and Mouth Disease | — | 2022-11-28 |
| Completed | Lot-to-lot Consistency of Quadrivalent Influenza Vaccine (Split Virion), Inactivated Seasonal Influenza | Phase 4 | 2022-11-27 |
| Completed | Immunogenicity and Safety of 23-valent Pneumococcal Polysaccharide Vaccine Pneumococcal Infections | Phase 4 | 2022-10-25 |
| Completed | A Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months Seasonal Influenza | Phase 3 | 2022-08-08 |
| Unknown | An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell) Hand, Foot and Mouth Disease | Phase 4 | 2022-07-30 |
| Completed | Immunogenicity and Safety Study of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Seasonal Influenza | Phase 3 | 2022-07-18 |
| Completed | A Clinical Trial to Observe the Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Target Population Pneumococcal Infectious Disease | — | 2022-07-02 |
| Completed | A Safety Study of Sabin Inactivated Poliovirus Vaccine in Infants Poliomyelitis | Phase 4 | 2022-06-13 |
| Unknown | Safety Observation of Enterovirus 71 Inactivated Vaccine (Vero Cell) Combined Immunization in Shanghai Hand, Foot and Mouth Disease | — | 2022-01-04 |
| Unknown | Safety and Immunogenicity Study of Booster Vaccination With Medium-dosage or High-dosage SARS-CoV-2 Inactivate COVID-19 | Phase 4 | 2021-12-17 |
| Completed | Study on Combined Vaccination With Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Va Influenza and Pneumonia | Phase 4 | 2021-11-13 |
| Completed | Immunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (Vero Cell) COVID-19 | Phase 4 | 2021-11-05 |
| Completed | A Study of Booster Immunization With COVID-19 Vaccine,Inactivated Co -Administration With Influenza Vaccine an COVID-19 | Phase 4 | 2021-10-15 |
| Completed | A Clinical Trial of Quadrivalent Influenza Vaccine in Children Aged 3-8 Years Old Seasonal Influenza | Phase 4 | 2021-10-10 |
| Completed | A Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine Pneumococcal Infections | Phase 4 | 2021-09-10 |
| Completed | An Immunity Persistence Study of Sabin Inactivated Poliovirus Vaccine(Vero Cell) After Four Doses Poliomyelitis | — | 2021-09-09 |
| Completed | Immunogenicity and Safety Assessment of Rabies Vaccine (Vero Cell) for Human Use, Freeze-dried Rabies (Healthy Volunteers) | Phase 3 | 2021-08-27 |
| Completed | Safety of Sabin Inactivated Poliovirus Vaccine in Adults, Children and Infants and Lot Consistency Immunogenic Poliomyelitis | Phase 3 | 2020-11-05 |
| Completed | Lot-consistency Clinical Trial of Sabin Strain Inactivated Polio Vaccine Poliomyelitis | Phase 3 | 2020-05-11 |
| Completed | Clinical Trial for Batch Consistency of EV71 Vaccine EV71 Vaccine | Phase 4 | 2019-09-19 |
| Completed | Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With Expanded Programme on Immunizatio Hand, Foot and Mouth Disease | Phase 4 | 2019-07-26 |
| Completed | Cross-neutralization Capacity of Immune Serum From Different Dosage of Sabin Inactivated Poliovirus Vaccine Im Poliomyelitis | N/A | 2019-07-20 |
| Completed | Clinical Trial of Recombinant Hepatitis B Vaccine (Hansenula Polymorpha, 10μg) Hepatitis B | Phase 1 | 2019-07-07 |
| Completed | Efficacy Trial of a Commercial EV71 Vaccine Hand, Foot and Mouth Disease | Phase 4 | 2019-03-26 |
| Completed | Clinical Trial of Enterovirus 71（EV71） Inactivated Vaccine in Children Aged 36-71 Months Hand, Foot and Mouth Disease | Phase 3 | 2019-03-10 |
| Completed | Immunogenicity and Safety of Two Different Commercial EV71 Vaccines Hand, Foot and Mouth Disease | Phase 4 | 2018-11-06 |
| Completed | A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a "2+1"Sequential Schedule With bOPV in Poliomyelitis | Phase 3 | 2018-06-12 |
| Completed | A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a '1+2' Sequential Schedule With bOPV in Poliomyelitis | Phase 3 | 2018-06-06 |
| Completed | Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (7.5μg/0.25ml) Seasonal Influenza | Phase 3 | 2018-02-06 |
| Completed | Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (15µg/0.5ml) Seasonal Influenza | Phase 3 | 2018-01-23 |
| Completed | An Immunogenicity and Safety Study of Sabin Inactivated Poliovirus Vaccine (Vero Cell) in 2-month-old Infants Poliomyelitis | Phase 3 | 2017-08-08 |
| Completed | Phase IV Clinical Trial, Immunogenicity and Safety of EV71 Vaccine Hand, Foot and Mouth Disease | Phase 4 | 2017-07-16 |
| Completed | Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) Vaccine Hand, Foot and Mouth Disease | — | 2017-05-20 |
| Completed | Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With EPI Vaccines Hand, Foot and Mouth Disease | Phase 4 | 2017-04-22 |
| Completed | Studies of the Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine Poliomyelitis | Phase 1 / Phase 2 | 2016-10-01 |
| Completed | Safety and Immunogenicity Study of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Children, Adults a Pneumococcal Infections | Phase 3 | 2015-04-01 |
| Completed | Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis Hepatitis A, Hepatitis B | Phase 4 | 2014-05-01 |
| Completed | The Immunogenicity and Safety of 2013-2014 Seasonal Trivalent Influenza Vaccine Influenza | Phase 4 | 2013-12-01 |
| Completed | A Follow-up Study for a Phase III, Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine Hand, Foot and Mouth Disease | — | 2013-03-01 |
| Completed | The Immunogenicity and Safety of 2012-2013 Trivalent Seasonal Influenza Vaccine Influenza | Phase 4 | 2012-11-01 |
| Completed | Immunogenicity and Safety of Three Consecutive Lots of a New Inactivated Enterovirus Type 71 (EV71) Vaccine Hand, Foot and Mouth Disease | Phase 3 | 2012-07-01 |
| Completed | An Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine Hand, Foot and Mouth Disease | Phase 3 | 2012-01-01 |
| Withdrawn | Safety and Immunogenicity of EV71 Vaccine With or Without Aluminum Adjuvant in Infants Infection, Viral, Enterovirus | Phase 2 | 2011-09-01 |
| Completed | Safety and Immunogenicity of an Inactivated EV71 Vaccine in Infants Infection, Viral, Enterovirus | Phase 2 | 2011-06-01 |
| Completed | Safety of an Inactivated Enterovirus Type 71 Vaccines in Healthy Children Hand-foot-mouth Disease, Infection; Viral, Enterovirus | Phase 1 | 2011-01-01 |
| Completed | Safety of an Inactivated Enterovirus Type 71 Vaccine in Healthy Adults Infection; Viral, Enterovirus | Phase 1 | 2010-12-01 |
| Completed | Immunogenicity and Interchangeability of Two Inactivated Hepatitis A Vaccines Hepatitis A | Phase 4 | 2010-04-01 |
| Completed | Sinovac, Pandemic Influenza A/H1N1 Vaccine in 6 to 35 Months Infants Influenza | Phase 4 | 2009-12-01 |
| Completed | Sinovac, H1N1 Vaccine + Trivalent Inactivated Influenza Vaccine, Adults Influenza | Phase 4 | 2009-10-01 |
| Completed | A Clinical Trial of Split-virion Influenza A/H1N1 Vaccines Influenza | Phase 4 | 2009-09-01 |
| Completed | A Clinical Trial With Influenza A/H1N1 Vaccines Influenza | Phase 4 | 2009-07-01 |
| Completed | Comparison of Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines in Young Adult Hepatitis A | Phase 4 | 2008-10-01 |
| Completed | The Fifth-year Follow-up Study for the Phase IV Clinical Trial of Hepatitis A Vaccine in Healthy Children Hepatitis A | — | 2008-10-01 |
| Completed | Phase IV Clinical Trial of an Influenza Split Vaccine Anflu Influenza | Phase 4 | 2007-09-01 |
| Completed | Safety and Immunogenicity of an Inactivated Pandemic Influenza Vaccine Pandemic Influenza, Prevention | Phase 2 | 2007-09-01 |
| Completed | Safety and Immunogenicity of Booster Dose of An Inactivated,Adjuvanted Whole-Virion Pandemic Influenza(H5N1)Va Pandemic Influenza Vaccine, Prevention, Pandemic Influenza | Phase 1 | 2007-01-01 |
| Completed | Safety, Immunogenicity, and Immune Persistence Study of an Inactivated Hepatitis A Vaccine Hepatitis A | Phase 4 | 2006-03-01 |
| Completed | Randomized, Double Blinded, Placebo Control Clinical Trial of Pandemic Influenza Inactive Vaccine on Healthy S Influenza | Phase 1 | 2005-12-01 |
| Completed | Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Children Influenza | Phase 2 | — |
| Completed | Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Adolescents Influenza | Phase 2 | — |